Cann Group Ltd
ASX:CAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
China Tungsten and Hightech Materials Co Ltd
SZSE:000657
|
CN |
Cann Group Ltd
EPS (Diluted)
Cann Group Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cann Group Ltd
ASX:CAN
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
EPS (Diluted)
-AU$1
|
CAGR 3-Years
30%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Cann Group Ltd
Glance View
Cann Group Ltd. operates research and development and cultivation facilities to grow medicinal cannabis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The firm has established research and cultivation facilities in Melbourne and is developing a cultivation facility near Mildura, Victoria. The company focuses on developing and supplying cannabis, cannabis resin and medicinal cannabis products into the Australian market. The firm has a cannabis research license and cannabis cultivation license. The cannabis cultivation license allows the Company to produce Australian grown material that can be prescribed for patient use. The company focuses on plant genetics, breeding, cultivation, extraction, analysis and production techniques to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.
See Also
What is Cann Group Ltd's EPS (Diluted)?
EPS (Diluted)
0
AUD
Based on the financial report for Dec 31, 2025, Cann Group Ltd's EPS (Diluted) amounts to 0 AUD.
